𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Placebo-controlled clinical trials in multiple sclerosis: Ethical considerations

✍ Scribed by Fred D. Lublin; Stephen C. Reingold

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
120 KB
Volume
49
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Glatiramer acetate in primary progressiv
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
✍ Jerry S. Wolinsky; Ponnada A. Narayana; Paul O'Connor; Patricia K. Coyle; Corey πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 349 KB πŸ‘ 2 views

## Abstract ## Objective To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. ## Methods A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3‐year, double‐blind tri